153 related articles for article (PubMed ID: 15944788)
1. Methylation of the MLH1 gene in hematological malignancies.
Matsushita M; Takeuchi S; Yang Y; Yoshino N; Tsukasaki K; Taguchi H; Koeffler HP; Seo H
Oncol Rep; 2005 Jul; 14(1):191-4. PubMed ID: 15944788
[TBL] [Abstract][Full Text] [Related]
2. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
[TBL] [Abstract][Full Text] [Related]
5. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
6. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
[TBL] [Abstract][Full Text] [Related]
7. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
Esteller M; Levine R; Baylin SB; Ellenson LH; Herman JG
Oncogene; 1998 Nov; 17(18):2413-7. PubMed ID: 9811473
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
9. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis.
Miyakura Y; Sugano K; Konishi F; Fukayama N; Igarashi S; Kotake K; Matsui T; Koyama Y; Maekawa M; Nagai H
Genes Chromosomes Cancer; 2003 Jan; 36(1):17-25. PubMed ID: 12461746
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
11. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
Seedhouse CH; Das-Gupta EP; Russell NH
Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
[TBL] [Abstract][Full Text] [Related]
12. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
[TBL] [Abstract][Full Text] [Related]
13. Mismatch repair and treatment resistance in ovarian cancer.
Helleman J; van Staveren IL; Dinjens WN; van Kuijk PF; Ritstier K; Ewing PC; van der Burg ME; Stoter G; Berns EM
BMC Cancer; 2006 Jul; 6():201. PubMed ID: 16879751
[TBL] [Abstract][Full Text] [Related]
14. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
[TBL] [Abstract][Full Text] [Related]
17. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
[TBL] [Abstract][Full Text] [Related]
18. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
[TBL] [Abstract][Full Text] [Related]
19. Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer.
Menigatti M; Di Gregorio C; Borghi F; Sala E; Scarselli A; Pedroni M; Foroni M; Benatti P; Roncucci L; Ponz de Leon M; Percesepe A
Genes Chromosomes Cancer; 2001 Aug; 31(4):357-61. PubMed ID: 11433526
[TBL] [Abstract][Full Text] [Related]
20. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
